Characterization of a pro-angiogenic, novel peptide from Russell's viper (Daboia russelii russelii) venom

dc.contributor.authorMajumder, Syamantak
dc.date.accessioned2021-10-02T17:48:19Z
dc.date.available2021-10-02T17:48:19Z
dc.date.issued2014-01
dc.description.abstractPresent report shows for the first time on the induction of in vitro angiogenesis by a 3.9 kDa novel peptide (RVVAP) purified from Russell's viper venom. Secondary structure of RVVAP is made up of 36.8% α-helix, 33.3% β pleated sheets and 29.9% turns. Optimum angiogenesis and significant elevation in endothelial migration were observed at 50 ng/ml of RVVAP treatment; above this concentration, progressive decrease in wound healing was noted. RVVAP (1.0 μg/ml) was non-cytotoxic to U87-MG, HeLa and HT-29 cells; however, increasing the RVVAP concentration above 500 ng/ml resulted in induction of chromosomal aberrations and delay in cell cycle kinetics of Chinese hamster ovary cells.en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0041010113004108?via%3Dihub
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2424
dc.language.isoenen_US
dc.publisherElsieveren_US
dc.subjectBiologyen_US
dc.subjectAngiogenesisen_US
dc.subjectChromosomal aberrationen_US
dc.subjectCytotoxicityen_US
dc.subjectRussell's viperen_US
dc.subjectWound healingen_US
dc.titleCharacterization of a pro-angiogenic, novel peptide from Russell's viper (Daboia russelii russelii) venomen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: